Provided by Tiger Trade Technology Pte. Ltd.

MBX Biosciences

60.25
-2.7500-4.37%
Volume:224.94K
Turnover:13.63M
Market Cap:2.90B
PE:-25.05
High:63.04
Open:62.30
Low:59.74
Close:63.00
52wk High:72.64
52wk Low:9.63
Shares:48.16M
Float Shares:27.63M
Volume Ratio:1.05
T/O Rate:0.81%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4052
EPS(LYR):-2.3824
ROE:-33.17%
ROA:-22.08%
PB:7.09
PE(LYR):-25.29

Loading ...

Is MBX Biosciences (MBX) Fairly Valued As New Leadership Takes Charge?

Simply Wall St.
·
Jul 18

MBX: Leadership Transition, Pipeline Visibility Support Maintained Buy Rating and Unchanged $91 Price Target

TIPRANKS
·
Jul 16

Analysts’ Top NA Picks: SanDisk Corp (SNDK), MBX Biosciences, Inc. (MBX)

TIPRANKS
·
Jul 16

Attovia Therapeutics Appoints John W. Smither to Board of Directors

THOMSON REUTERS
·
Jul 15

How MBX Biosciences’ New CEO-Chairman Structure Could Reframe the MBX Investment Narrative

Simply Wall St.
·
Jul 14

Wall Street Analysts Are Bullish on Top NA Picks

TIPRANKS
·
Jul 14

Stocks to Watch: Lulu's Fashion Lounge Holdings, MBX Biosciences, Rithm Property Trust

Dow Jones
·
Jul 14

MBX Biosciences Announces CEO Transition and Leadership Updates

TIPRANKS
·
Jul 14

MBX Biosciences Falls After Executive Shakeup

Reuters
·
Jul 14

MBX Biosciences Names Steve Hoerter CEO, Replacing Kent Hawryluk

Reuters
·
Jul 14

Mbx Biosciences - All Leadership Changes Effective Immediately

THOMSON REUTERS
·
Jul 14

Mbx Biosciences - Appoints Steve Hoerter as Chairman and CEO

THOMSON REUTERS
·
Jul 14

Mbx Biosciences - Kent Hawryluk Steps Down as President, CEO and Board Member

THOMSON REUTERS
·
Jul 14

Mbx Biosciences - Appoints John Smither as Chief Financial Officer

THOMSON REUTERS
·
Jul 14

Mbx Biosciences Announces Executive Leadership Transition to Support the Company’s Next Phase of Growth

THOMSON REUTERS
·
Jul 14

Press Release: MBX Biosciences Announces Executive Leadership Transition to Support the Company's Next Phase of Growth

Dow Jones
·
Jul 14

MBX Biosciences on Track for Record High Close

Dow Jones
·
Jul 06

MBX Biosciences Completes STEADI Trial, Putting Imapextide on Investors’ Radar

TIPRANKS
·
Jul 03

MBX's Flagship Drug Trial Met Expectations But Perhaps Some Investors Wanted More -- Market Talk

Dow Jones
·
Jun 13

Analysts’ Top Healthcare Picks: MBX Biosciences, Inc. (MBX), Kura Oncology (KURA)

TIPRANKS
·
Jun 13